Related Experiment Video
Updated: May 17, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Clinical characteristics of active tuberculosis with pulmonary thromboembolism
Yue Jia1, Haimei Bo2, Liang Tang3,4
1Haihe Clinical College, Tianjin Medical University, Tianjin, China.
Background:
In this study, we summarized clinical characteristics in patients with active tuberculosis (ATB) complicated by pulmonary thromboembolism (PTE), to further determine the influencing factors of PTE in ATB patients.
Methods:
The study population consisted of ATB patients who were first seen and hospitalized from January 2014 to January 2022 in Haihe Hospital. The diagnosis of PTE was confirmed by computed tomography pulmonary angiography (CTPA), and the ATB patients were divided into a test group with PTE and a control group without PTE in this study. The Padua score is a guideline-recommended validated tool for venous thromboembolism (VTE) risk assessment in medical patients. The two groups were retrospectively compared and analyzed by clinical characteristics, including gender, age, Padua score, clinical symptoms, tuberculosis (TB) classification, routine blood tests, coagulation indexes, inflammatory indexes, imaging manifestations, and rifampicin application, etc. RESULTS: There are 43 patients diagnosed with ATB complicated by PTE in this study, including 27 males (62.8%) and 16 females (37.2%), with a ratio of 1.69. Compared with the control group, test group showed higher Padua score, more frequent chest tightness and dyspnea, higher D-dimer, but with lower arterial partial pressure of carbon dioxide. Pathologically, more lobes in the test group patients had pulmonary lesions, with higher occurance in the lower and middle lobes, more image manifestations of pulmonary infarction and atelectasis. Lastly, CTPA traits showed that peripheral types are more than central types in the test group.
Conclusions:
ATB patients should be alert to the occurrence of PTE and consider initiating anticoagulant therapy, if they have anemia, hypoproteinemia, increased D-dimer, increased inflammatory indicators, serious imaging, more pulmonary lobe involvement and lower lobe involvement.
More Related Videos
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
09:54Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Other Pulmonary Disorders